Apart from that, Dong et al. [29], having enrolled 125 patients with AIS, investigated the potential utility of copeptin as a prognostic tool for outcome and mortality during a 90-day follow-up from stroke onset. Here, AVP is linked to androgen insensitivity syndrome.